Abeona (ABEO) CFO Joseph Vazzano Sells 9,191 Shares

What Happened

• Joseph Walter Vazzano, Chief Financial Officer of Abeona Therapeutics, reported the sale of 9,191 shares on 2026-09-29. The shares were disposed at a weighted-average price of $5.16 per share, totaling approximately $47,385. The Form 4 lists the transaction as an open market or private sale (code S).
• The filing notes the sale was to cover tax obligations associated with the vesting of restricted stock awards, so this was a tax-withholding sale rather than a purchase (not a bullish signal).

Key Details

• Transaction date: 2026-09-29 (filed on the same date; no late filing indicated).
• Quantity and value: 9,191 shares sold; weighted-average price $5.16; aggregate proceeds ~$47,385.
• Price range: shares were sold in multiple transactions at prices between $5.1150 and $5.3000 (footnote F2). The reporting person will provide a breakdown by price on request.
• Reason: sale to cover tax withholding on vested restricted stock (footnote F1).
• Shares owned after transaction: not specified in the provided filing excerpt.

Context

• Tax-withholding sales tied to vesting are routine administrative transactions and do not by themselves indicate the insider’s view on the company’s prospects. If you want the exact number of shares sold at each price within the reported range, the filer has agreed to provide that breakdown upon request.